基本信息
views: 42
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Stelios T. Andreadis received his MS (Applied Mathematics) and PhD degree in Chemical Engineering from the University of Michigan studying the dynamics of retroviral gene transfer for gene therapy. He then pursued postdoctoral training at the Center for Engineering in Medicine at Harvard Medical School, where he worked in the areas of gene therapy, tissue engineering and regenerative medicine. Currently he serves as SUNY Distinguished Professor of Chemical and Biological Engineering, Biomedical Engineering and Member of the Center of Excellence in Bioinformatics and Life Sciences at the University at Buffalo, State University of New York. He is the Director of the Cell, Gene and Tissue Engineering Center and served as the Director of the Stem Cells in Regenerative Medicine (SCiRM) Training Program that was funded by NYSTEM to train students in stem cell biology and bioengineering and applications of stem cells in regenerative medicine. He served as CBE department Chair for two terms from 2012 to 2018.
His research interests span a wide spectrum from fundamental to technological to pre-clinical/translational research. He has made significant research contributions in the areas of stem cell bioengineering; vascular, skin and gland tissue engineering and regeneration; molecular design of biomaterials; protein and gene delivery, and lentiviral arrays for high throughout pathway analysis of stem cell differentiation and reprogramming. He co-founded a company (Angiograft, LLC) to commercialize the cell-free vascular grafts that were developed in his laboratory as arterial replacement grafts for treatment of cardiovascular disease.
Professor Andreadis’ research has received continuous funding since 1999 from NIH, NSF, NYSTEM and private foundations (Whitaker, Oishei), totaling more than $20 million. He is the recipient the Whitaker Foundation Young Investigator Award (1999), the NSF CAREER Award (2000), the Exceptional Scholar Young Investigator Award (UB, 2003), Exceptional Scholar: Sustained Achievement Award (UB, 2009) and the SUNY Chancellor’s Award for Excellence in Scholarship (2014). He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE, 2009) and of the Biomedical Engineering Society (BMES, 2016). In 2018 he was promoted to the rank of SUNY Distinguished Professor. He has published 140 peer-reviewed publications and conference proceedings and delivered more than 75 invited seminars. He has advised 28 PhD students, 18 MS students, 4 post-doctoral research fellows and more than 40 undergraduate researchers.
His research interests span a wide spectrum from fundamental to technological to pre-clinical/translational research. He has made significant research contributions in the areas of stem cell bioengineering; vascular, skin and gland tissue engineering and regeneration; molecular design of biomaterials; protein and gene delivery, and lentiviral arrays for high throughout pathway analysis of stem cell differentiation and reprogramming. He co-founded a company (Angiograft, LLC) to commercialize the cell-free vascular grafts that were developed in his laboratory as arterial replacement grafts for treatment of cardiovascular disease.
Professor Andreadis’ research has received continuous funding since 1999 from NIH, NSF, NYSTEM and private foundations (Whitaker, Oishei), totaling more than $20 million. He is the recipient the Whitaker Foundation Young Investigator Award (1999), the NSF CAREER Award (2000), the Exceptional Scholar Young Investigator Award (UB, 2003), Exceptional Scholar: Sustained Achievement Award (UB, 2009) and the SUNY Chancellor’s Award for Excellence in Scholarship (2014). He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE, 2009) and of the Biomedical Engineering Society (BMES, 2016). In 2018 he was promoted to the rank of SUNY Distinguished Professor. He has published 140 peer-reviewed publications and conference proceedings and delivered more than 75 invited seminars. He has advised 28 PhD students, 18 MS students, 4 post-doctoral research fellows and more than 40 undergraduate researchers.
Research Interests
Papers共 180 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Membrane Sciencepp.122895, (2024)
Georgios Tseropoulos,Pihu Mehrotra, Ashis Kumer Podder, Emma Wilson,Yali Zhang,Jianmin Wang,Alison Koontz,Nan Papili Gao, Rudiyanto Gunawan, Song Liu,Laura M Feltri,Marianne E Bronner,
APL Bioengineeringno. 2 (2024): 026127-026127-17
Cardiovascular Researchno. 8 (2024): 839-854
Pihu Mehrotra, James Jablonski, John Toftegard, Yali Zhang,Shahryar Shahini,Jianmin Wang,Carey W Hung,Reilly Ellis,Gabriella Kayal,Nika Rajabian,Song Liu,Kelly Roballo,
Research square (2024)
Science advancesno. 28 (2024): eadk9918-eadk9918
Debanik Choudhury,Na Rong, Hamsa Vardini Senthil Kumar, Sydney Swedick,Ronel Z. Samuel,Pihu Mehrotra, John Toftegaard,Nika Rajabian,Ramkumar Thiyagarajan, Ashis K. Podder,Yulun Wu,Shahryar Shahini,
CELL REPORTSno. 2 (2024): 113738-113738
Acta biomaterialia (2023): 147-158
Load More
Author Statistics
#Papers: 175
#Citation: 5247
H-Index: 43
G-Index: 65
Sociability: 6
Diversity: 4
Activity: 78
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn